Telehealth Anxiety Prescribing: What Psychiatric NPs Can Do in Georgia

You’re a psychiatrist or PMHNP who treats anxiety disorders. Your patients are searching online for care — some just moved states, others can’t find a local provider, many prefer the convenience of video visits. You’re wondering: Can I prescribe anxiety medications via telehealth? What about controlled substances like benzodiazepines? Do the rules differ if I’m an NP versus an MD? And what’s the reimbursement picture?

Here’s the reality: Yes, you can prescribe anxiety medications via telehealth in 2026 — including controlled substances — but the details vary significantly by your credentials (psychiatrist vs PMHNP) and which state you’re licensed in. Federal COVID-era flexibilities that allowed telehealth prescribing of controlled substances have been extended through December 2026, giving you continued ability to manage anxiety patients remotely. However, state-level scope of practice laws create a patchwork: psychiatrists enjoy full prescribing authority everywhere, while PMHNPs face varying degrees of oversight depending on whether they practice in a full practice authority state or a restricted one.

This guide breaks down exactly what psychiatrists and PMHNPs can do when prescribing anxiety medications via telehealth, how reimbursement works, and what the regulations look like in key states (California, Texas, Florida, New York, Pennsylvania, Illinois). Whether you’re already practicing telepsychiatry or considering it, understanding these rules helps you serve more patients legally and profitably.

What Psychiatrists Can Prescribe for Anxiety via Telehealth (Federal & State Rules)

Bottom line for MDs/DOs: As a board-certified psychiatrist, your prescribing authority for anxiety disorders is identical via telehealth as it is in-person — you can evaluate patients online and prescribe any appropriate medication, including SSRIs, SNRIs, benzodiazepines, or even Schedule II stimulants if clinically indicated for comorbid conditions.

Federal Telehealth Prescribing Rules (The DEA Extension Through 2026)

Historically, the Ryan Haight Act required at least one in-person visit before prescribing controlled substances. That rule was suspended during COVID-19 to allow remote prescribing of medications like Adderall and Xanax via telemedicine. Good news: these flexibilities remain in effect through December 31, 2026. The DEA and HHS extended them specifically to prevent a ‘telemedicine cliff’ where millions of patients would lose access to care.

What this means for anxiety treatment:

• You can conduct an initial psychiatric evaluation by secure video and prescribe benzodiazepines (alprazolam, clonazepam, lorazepam) without ever seeing the patient in person
• You can manage ongoing medication adjustments remotely
• You can prescribe stimulants for comorbid ADHD/anxiety presentations
• In 2024 alone, over 7 million controlled substance prescriptions were written via telemedicine under these rules

The DEA is working on permanent regulations expected late 2026 — they may introduce a special telemedicine prescribing registration or reinstate some exam requirements. Stay alert to those changes, but for now you have clear authority to practice telepsychiatry with your full prescriptive scope.

State-Specific Telehealth Prescribing Rules

While federal law sets the floor, some states add conditions:

Florida: Explicitly permits telehealth prescribing of Schedule II controlled substances when treating psychiatric disorders — meaning you can prescribe stimulants or other controlled meds for anxiety/depression via video. (Benzodiazepines are Schedule IV, so even easier.) Florida requires you check the state PDMP (E-FORCSE) before prescribing any controlled substance. One caveat: if you’re practicing in Florida via the out-of-state telehealth provider registration (not a full FL license), you cannot prescribe controlled substances remotely.

Texas: Allows telehealth prescribing for psychiatric conditions including anxiety. Texas does ban telemedicine treatment of chronic pain with controlled drugs, but anxiety treatment doesn’t fall under that prohibition. You must establish a valid patient-practitioner relationship via live video and check the Texas PMP database. Texas is part of the Interstate Medical Licensure Compact (IMLC), making it easier to get licensed if you’re based elsewhere.

California: No unique restrictions beyond federal rules. You can prescribe any anxiety medication via telehealth (SSRIs, benzos, etc.) as long as you conduct an appropriate video evaluation. California has telehealth payment parity laws ensuring insurers reimburse virtual visits equally — a financial win for providers. California is not in the IMLC, so out-of-state psychiatrists need a full CA medical license to treat California patients.

New York: No state-level telehealth prescribing restrictions for controlled substances. You must check New York’s PDMP (iSTOP) for every controlled substance prescription (NY has strict PDMP mandates). Note: Medicare patients in NY may eventually need periodic in-person visits under federal rules, but enforcement of that requirement has been delayed through 2024–2025. Verify current Medicare telehealth policy if you serve many Medicare beneficiaries.

Pennsylvania & Illinois: Neither imposes telehealth-specific prescribing prohibitions for mental health. Follow standard of care, document your video evaluation appropriately, and check the state PDMP (Pennsylvania’s ABC-MAP, Illinois’ PMP). Both states have insurance coverage for tele-mental health services, often at parity with in-person rates.

The pattern: Psychiatrists can confidently prescribe anxiety medications via telehealth nationwide, provided they’re licensed in the state where the patient is located, adhere to PDMP requirements, and document appropriately. The federal extension through 2026 removes the biggest historical barrier (the in-person exam requirement for controlled substances).

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNP vs Psychiatrist: How Prescribing Authority Differs for Anxiety Medications

If you’re a Psychiatric Mental Health Nurse Practitioner (PMHNP), your ability to prescribe anxiety medications — particularly controlled substances like benzodiazepines — depends heavily on which state you’re licensed in. Unlike psychiatrists who have uniform authority across all states, PMHNPs navigate a patchwork of scope of practice laws.

Full Practice Authority States: PMHNPs Practice Like Psychiatrists

About half of U.S. states grant PMHNPs Full Practice Authority (FPA), meaning you can evaluate, diagnose, and prescribe medications independently without physician supervision. In these states, your prescribing power for anxiety disorders matches a psychiatrist’s.

Examples of FPA states (as of 2026):

• New York: Achieved full FPA in 2022 when Governor Hochul signed legislation removing the collaborative agreement requirement. New York PMHNPs can now open independent practices and prescribe all anxiety medications (SSRIs, SNRIs, benzodiazepines) on their own authority.
• Arizona, Oregon, Washington, New Mexico: Long-standing FPA states where experienced PMHNPs operate autonomously.
• California (transitioning): California’s AB 890 created a phased pathway to independence. As of January 2023, NPs with 3+ years experience can practice without physician protocols in group settings (103 NP status). Starting in 2026, those NPs can apply for full independent practice authority (104 NP status) and operate solo practices without supervision — a major shift for California mental health access.

In FPA states, the difference between a PMHNP and a psychiatrist for anxiety treatment is minimal from a legal standpoint. You assess the patient via telehealth, initiate SSRIs or other first-line treatments, and can prescribe benzodiazepines when clinically appropriate. You must still follow all controlled substance regulations (DEA registration, PDMP checks), but you don’t need a physician to sign off.

Reduced/Restricted Practice States: Collaboration Required

In states without FPA, PMHNPs must maintain a collaborative agreement with a physician to prescribe medications. The physician doesn’t need to see every patient or co-sign every prescription in real-time, but they supervise through periodic chart reviews and must be available for consultation.

Examples of collaborative/restricted states:

Texas: One of the most restrictive. PMHNPs need a Prescriptive Authority Agreement with a Texas physician to prescribe anything. Additionally, Texas law prohibits NPs from prescribing Schedule II controlled substances in most outpatient settings (exceptions: hospital-based care, hospice, or terminally ill patients). For anxiety treatment this means:

• You can prescribe benzodiazepines (Schedule IV) if your collaborating physician authorizes it
• You cannot independently prescribe stimulants (Schedule II) for comorbid ADHD outside hospital settings — the physician would need to prescribe those
• Texas caps supervision at 7 NPs per physician for prescriptive authority

The collaboration requirement adds logistical burden (finding a willing psychiatrist, often paying a fee for the agreement) and geographic constraints (physician typically must be within 75 miles).

Florida: PMHNPs must practice under a written protocol with a physician. Florida law limits NPs to a 7-day supply of controlled substances UNLESS you’re a psychiatric nurse practitioner treating a mental health condition — in which case you can prescribe longer supplies of benzodiazepines or other anxiety meds. You still need the physician protocol on file. Florida’s recent reforms granted independence to some experienced NPs in primary care, but psychiatric NPs were excluded from that pathway — you still need supervision.

Pennsylvania: Requires collaborative agreements for all NP practice and prescribing. The physician must countersign a percentage of your charts (often 100% for Schedule II prescriptions within 24 hours). For anxiety medication management, this means if you want to prescribe a benzodiazepine, it must be explicitly authorized in your collaboration agreement. Pennsylvania has considered FPA legislation but hasn’t passed it as of 2026.

Illinois (transitional): Illinois starts NPs with required collaboration but offers a path to FPA after 4,000 clinical hours + 250 hours of continuing education. Once you meet those thresholds and apply for FPA, you can practice independently — however, even FPA NPs in Illinois need a one-time physician consultation agreement specifically for prescribing benzodiazepines and Schedule II narcotics. Essentially, a psychiatrist must attest that you’ll be prescribing those classes, but after that sign-off you can prescribe them independently. It’s a middle-ground approach.

Controlled Substances: The Key Sticking Point

Benzodiazepines (alprazolam/Xanax, clonazepam/Klonopin, lorazepam/Ativan) are Schedule IV controlled substances. Every PMHNP who prescribes them must:

• Have a DEA registration (in addition to state controlled substance license where required)
• Check the state PDMP before prescribing
• In restricted states, have explicit authorization in their collaborative agreement

Some states add extra hurdles. Texas and Florida restrict NP authority for Schedule II stimulants (often used for treatment-resistant anxiety with comorbid ADHD). Pennsylvania requires physician countersignature for Schedule II within 24 hours. New York (post-FPA) allows NPs to prescribe Schedule II independently.

The practical impact: In a restricted state, if you want to manage a patient’s anxiety with a benzodiazepine, you need a psychiatrist or physician willing to collaborate — and they may charge $2,000–5,000 annually for that relationship. In an FPA state, you operate independently with no such burden.

What This Means for Telehealth Platforms

Telehealth platforms like Klarity must navigate these state-by-state rules. They either:

1. Pair PMHNPs with collaborating physicians where required (built into the platform infrastructure)
2. Focus recruitment in FPA states where PMHNPs can operate autonomously
3. Credential both psychiatrists and PMHNPs to maximize patient access across all states

For you as a provider, joining a platform that handles compliance means you can focus on clinical care while they manage the legal complexity of multi-state practice.

Medication Management Reimbursement: What Psychiatrists and PMHNPs Actually Get Paid

Understanding reimbursement is critical when evaluating telepsychiatry opportunities. Here’s what psychiatric medication management pays in 2026 across different payer types.

Medicare Reimbursement (The Benchmark)

Medicare sets rates that many private insurers follow. For anxiety medication management:

Common scenarios:

• Initial psychiatric evaluation (CPT 90792): ~$202 (Medicare 2026 national rate)
• 15-minute medication follow-up (CPT 99213): ~$95
• 25-minute moderate-complexity visit (CPT 99214): ~$136
• Add psychotherapy (30 min, CPT 90833): adds ~$81 to the visit

These rates are quite good relative to other specialties for time spent — Medicare recognizes the shortage of psychiatric providers and reimburses accordingly. If you provide medication management plus brief therapy (common in anxiety treatment), you can bill both the E/M code and the therapy add-on, easily reaching $150–180 for a 30-minute visit.

Telehealth parity: Medicare currently pays telehealth visits at the same rate as in-person through extended COVID-era rules (now through late 2024/early 2025 with further extensions likely into 2026). This means a telepsychiatry med check pays the same $95 as an in-office visit.

One caveat: Medicare had proposed requiring periodic in-person visits (within 6 months initially, then annually) for tele-mental health services. Enforcement of this rule has been delayed multiple times. If it eventually takes effect, you’d need to see Medicare patients in person occasionally to continue billing for telehealth — something to monitor if you serve many Medicare beneficiaries.

Medicaid Reimbursement (Lower Rates, Higher Volume)

Medicaid pays significantly less than Medicare — typically 50-60% of Medicare rates:

• 90792 (psych eval): ~$85 (vs $202 Medicare)
• 99213 (med check): ~$40-50 (vs $95 Medicare)

The lower rates are offset somewhat by:

• High patient volume (many anxiety patients are Medicaid-enrolled)
• Low overhead in telehealth (no office rent)
• Many states now require Medicaid to cover telehealth at parity with in-person
• Some states have increased Medicaid behavioral health rates to address shortages

If you see a high volume of Medicaid patients efficiently (e.g., 20+ appointments weekly), the total can be financially viable even at lower per-visit rates.

Private Insurance (Best Rates, Variable)

Commercial insurers typically pay 100-150% of Medicare rates depending on your contract. Common ranges for anxiety medication management:

• 99213 (15-min med check): $80–130
• 99214 (25-min visit): $120–180
• 90792 (initial eval): $150–250+

Telehealth parity laws in many states (California AB 744, Illinois, New York) require private insurers to reimburse telehealth visits at the same rate as in-person. This removes the historical penalty where virtual visits might be paid at 80% of in-office rates.

Out-of-network opportunity: Some psychiatrists opt out of insurance panels entirely and charge cash rates ($200–350 per session in metro areas). Patients may use out-of-network benefits for partial reimbursement. This model offers higher per-visit income but requires patients who can afford it.

PMHNP Reimbursement: The 85% Rule

When a PMHNP bills under their own NPI, Medicare reimburses at 85% of the physician rate for the same service. For example:

• If a psychiatrist gets $100 for a med check, an NP gets $85
• If a psychiatrist gets $200 for an initial eval, an NP gets $170

Some practices use ‘incident to’ billing (billing NP visits under the physician’s NPI at 100% rate), but this requires strict supervision criteria and doesn’t work well in telehealth or psychiatric care where the NP is the primary provider.

Private insurers vary — some pay NPs at 85-90% of physician rates, others pay equally (especially in states with parity laws). Medicaid in some states pays NPs the same as MDs; others maintain the differential.

What this means: On a telehealth platform, psychiatrists may generate slightly more revenue per visit than PMHNPs, but NP salaries are typically lower than MD salaries, so the economics can work for both.

Coding and Documentation Tips

To maximize reimbursement:

• Document thoroughly: Since 2021, E/M coding is based on time or medical decision-making. If you spend 25 minutes on a visit (including reviewing labs, adjusting meds, counseling on side effects), that supports a 99214, not just a 99213.
• Add therapy when appropriate: If you provide supportive therapy during a med check (common in anxiety treatment — 20 minutes discussing coping strategies), bill the psychotherapy add-on code (90833 for 30 min, 90836 for 45 min). This significantly increases your reimbursement.
• Use 90792 for initial evaluations: Don’t default to 99204/99205 for new patients — 90792 is specifically for psychiatric diagnostic evaluation and reimburses better.
• Note telehealth: Document that the visit was conducted via telehealth and include patient consent for remote care (some payers require this).

Real-World Economics: Platform vs DIY

Many providers search for information on patient acquisition costs when considering whether to join a platform like Klarity or build their own telehealth practice. Here’s the reality:

DIY marketing for a psychiatric practice:

• SEO: Takes 6-12 months of consistent content and technical investment before generating meaningful patient flow. Cost: $1,000–3,000/month for agency/consultant help.
• Google Ads: Mental health keywords cost $15–40+ per click. Most clicks don’t convert to booked patients. Realistic cost per booked patient: $200–400+ when you factor in ad spend, landing page optimization, and lead qualification.
• Psychology Today/Zocdoc listings: Monthly fees ($30–200) plus Zocdoc charges $35–100+ per booking. You compete with hundreds of other providers on the same platform.
• Total monthly marketing spend for solo practice: Easily $3,000–5,000/month with uncertain results, especially in the first year.

Telehealth platform model (like Klarity):

• Pay-per-appointment model: You pay a standard listing fee per new patient lead (similar to Zocdoc’s per-booking fee)
• No upfront marketing spend or monthly subscriptions
• Pre-qualified patients matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

The value proposition: Instead of gambling $5,000/month on marketing that may or may not work, you pay only when a qualified patient books with you. That’s guaranteed ROI. You’re essentially outsourcing patient acquisition to a platform that’s already done the SEO, paid advertising, and lead generation work at scale.

For most providers — especially those starting out, scaling up, or preferring clinical work over marketing — the platform model removes financial risk entirely.

State-by-State Regulatory Summary (2026)

FAQ: Anxiety Prescribing via Telehealth

Can psychiatrists prescribe benzodiazepines via telehealth in 2026?

Yes. Federal rules allow psychiatrists to prescribe controlled substances including benzodiazepines (Xanax, Klonopin, Ativan) via telehealth without an initial in-person visit through December 2026. You must be licensed in the state where the patient is located and check the state PDMP before prescribing.

Can PMHNPs prescribe anxiety medications independently?

It depends on the state. In Full Practice Authority states (New York, Arizona, etc.), PMHNPs can prescribe all anxiety medications including benzodiazepines independently. In restricted states (Texas, Florida, Pennsylvania), they need a collaborative agreement with a physician and explicit authorization to prescribe controlled substances.

Do Medicare and private insurance pay the same for telehealth as in-person?

Currently yes for Medicare (through extended COVID-era rules into 2025-2026) and in states with telehealth parity laws (California, Illinois, New York) for private insurance. Some states don’t mandate parity, but many insurers voluntarily pay equally for tele-mental health services.

What’s the difference between a psychiatrist and PMHNP for prescribing anxiety meds?

Psychiatrists have unrestricted prescribing authority in all 50 states. PMHNPs’ authority varies by state — from full independence matching psychiatrists (FPA states) to requiring physician supervision (restricted states). Both can effectively manage anxiety medications, but the legal framework differs.

How much does a psychiatric medication management visit reimburse?

Medicare pays ~$95 for a 15-minute follow-up (99213) and ~$202 for an initial evaluation (90792) as of 2026. Private insurance typically pays 100-150% of Medicare rates. Medicaid pays 50-60% of Medicare rates. Adding brief therapy increases reimbursement significantly.

What anxiety medications can NPs prescribe via telehealth?

In FPA states, PMHNPs can prescribe SSRIs, SNRIs, buspirone, beta-blockers, and benzodiazepines via telehealth. In restricted states, they can prescribe these if authorized by their collaborative agreement. Some states (Texas, Florida) restrict NP prescribing of Schedule II stimulants, but benzodiazepines (Schedule IV) are generally accessible.

Are telehealth prescribing rules permanent?

The current federal flexibility allowing controlled substance prescribing via telehealth is extended through December 2026. The DEA is working on permanent regulations expected late 2026. State telehealth parity laws (for insurance payment) vary — some are permanent, others are extensions from COVID-era rules.

The Bottom Line: How to Leverage Telehealth for Anxiety Treatment in 2026

Whether you’re a psychiatrist or PMHNP, telehealth offers unprecedented opportunity to serve the millions of Americans struggling with anxiety disorders — particularly in underserved areas facing severe provider shortages.

For psychiatrists:

• You have full prescribing authority via telehealth nationwide through at least 2026
• Reimbursement is solid (Medicare pays well for psychiatric E/M, private insurance often better)
• The main barriers are licensing (you need a license in each state where you treat patients) and staying current on evolving federal DEA rules

For PMHNPs:

• Your authority depends on state law — prioritize FPA states for maximum autonomy
• In restricted states, you can still practice effectively but need physician collaboration (which platforms like Klarity can facilitate)
• Reimbursement is slightly lower than psychiatrists (85% of physician rates for Medicare) but often offset by lower salary expectations and high demand

The economic choice:Building a solo telehealth practice from scratch requires significant marketing investment ($3,000–5,000/month) with 6-12 month ramp-up time before meaningful patient flow. DIY marketing can work if you have the budget, expertise, and patience.

Joining a telepsychiatry platform removes that risk entirely. Instead of upfront marketing spend, you pay only when qualified patients book with you. The platform handles patient acquisition, insurance credentialing, telehealth infrastructure, and compliance — you focus on clinical care.

For providers starting out, scaling up, or simply preferring to practice medicine rather than market it, the platform model offers guaranteed ROI: every appointment generates income, with no wasted ad spend on clicks that don’t convert.

Ready to see more anxiety patients without the marketing gamble? Klarity Health connects psychiatrists and PMHNPs with pre-qualified patients across multiple states, handling all the infrastructure while you maintain control of your schedule. Join a network of providers who’ve traded unpredictable DIY marketing for predictable, high-quality patient flow.

Explore joining Klarity’s provider network to start seeing more anxiety patients this month — no upfront costs, no marketing risk, just clinical work that pays.

Sources and References

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (Official .gov source, January 2, 2026) www.hhs.gov

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (Official state .gov, 2024 Statutes effective 2024-25) www.flsenate.gov, www.flsenate.gov

3. California Board of Registered Nursing – AB 890 Implementation FAQs (Official state board, Updated 2024) rn.ca.gov

4. NPNY announcement – ‘NP Modernization Act Passes in NY’ (Professional Association Blog, April 9, 2022) npny.enpnetwork.com

5. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (Industry/Professional Blog, 2025 rates for 2026) therathink.com

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs